Prevalence of Premenstrual Syndrome in Women of Reproductive Age
Launched by UNIVERSITÉ DE REIMS CHAMPAGNE-ARDENNE · Nov 2, 2023
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the prevalence of Premenstrual Syndrome (PMS) among women who are of reproductive age. PMS includes a variety of physical and emotional symptoms that many women experience before their menstrual period begins. These symptoms can significantly affect a woman's daily life, but often go unreported because women may think they are normal or not serious enough to discuss with their healthcare providers. The goal of this study is to better understand how common PMS really is, so that more women can receive the help they need.
To participate in this trial, women must be over 18 years old and still have regular menstrual cycles, meaning they are not in menopause or have had a hysterectomy. The study is not currently recruiting participants, but once it begins, women who qualify will be asked to share their experiences with PMS. This research is important because it may lead to better recognition and treatment options for those who suffer from PMS, improving their quality of life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women in childbearing age, i.e., menstrual or secondary amenorrhoea, non-menopausal
- • Over 18 years of age
- • Agreeing to participate in the study
- Exclusion Criteria:
- • Menopause
- • Having had a hysterectomy
- • With primary amenorrhea
- • Protected by law
- • Refusing to participate in the study
About Université De Reims Champagne Ardenne
Université de Reims Champagne-Ardenne (URCA) is a distinguished higher education institution located in France, recognized for its commitment to advancing research and innovation in various fields, including health sciences. With a strong focus on interdisciplinary collaboration, URCA actively engages in clinical trials aimed at improving patient outcomes and contributing to medical knowledge. The university fosters a dynamic research environment, equipped with state-of-the-art facilities and a network of experienced professionals, ensuring the integrity and rigor of its clinical studies while prioritizing ethical standards and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reims, , France
Patients applied
Trial Officials
Kristner Pauline, Dr
Principal Investigator
CH Épernay
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported